Pancreatic cancer is widely known as one of the most dangerous and difficult cancers to treat. Among the different types of pancreatic cancer, the most common and aggressive form is called pancreatic ductal adenocarcinoma, often shortened to PDAC.
This disease develops in the ducts of the pancreas, which are the small tubes that help carry digestive fluids from the pancreas to the small intestine. The pancreas itself is a vital organ that helps the body digest food and control blood sugar levels.
Unfortunately, pancreatic cancer is usually discovered very late. In the early stages, the disease often causes few or no symptoms. Because of this, many patients are diagnosed only after the cancer has already spread to other parts of the body.
When this happens, treatment becomes extremely difficult. Even with surgery, chemotherapy, and other treatments, the survival rate for PDAC remains very low. Today, only about 8 out of every 100 people diagnosed with this cancer live for more than five years after diagnosis.
Because of this grim outlook, scientists around the world are working hard to understand pancreatic cancer better and to find new ways to treat it. A new study from researchers at the Francis Crick Institute in London has brought fresh hope.
Their research, which was published in the scientific journal Nature Cell Biology, reveals an important clue that may help doctors develop new treatments in the future.
The research team was led by Dr. Axel Behrens. The scientists focused their attention on a special group of cells inside tumors known as cancer stem cells. To understand why these cells are important, it helps to first know what stem cells are.
In a healthy body, stem cells play a useful role. They help repair tissues and replace damaged cells. For example, if a part of the body is injured, stem cells can create new cells to help the tissue heal.
However, cancer stem cells behave very differently. Instead of helping the body repair itself, these cells help tumors grow and spread. Cancer stem cells are able to produce many new cancer cells and can also transform into different types of tumor cells.
This ability makes them especially dangerous. Scientists believe that cancer stem cells are one of the key reasons cancers continue to grow even after treatment.
The first goal of Dr. Behrens and his team was to find a way to identify these cancer stem cells. If doctors can recognize them clearly, they may be able to target them with new treatments. To do this, the researchers carefully studied the genetic activity inside pancreatic tumor cells.
During their investigation, the scientists discovered that many cancer stem cells carried a particular protein on their surface. This protein is called CD9. Proteins like CD9 sit on the outside of cells and often help control how cells communicate or interact with their environment.
The researchers found that CD9 appeared on cancer stem cells during both the early stages and later stages of tumor growth. This finding was important because it suggested that CD9 could act as a marker. In other words, it could help scientists identify cancer stem cells inside pancreatic tumors.
But the discovery became even more interesting. The team realized that CD9 was not just a marker that helps identify these dangerous cells. It also appeared to help the cancer become more aggressive.
To test this idea, the scientists carried out experiments using mice with pancreatic tumors. They changed the amount of CD9 inside the tumor cells and observed what happened. When the amount of CD9 was reduced, the tumors grew more slowly and remained smaller. When the level of CD9 was increased, the tumors grew faster and became larger.
The team also examined medical data from patients with pancreatic cancer. They discovered that people whose tumors contained high levels of CD9 generally had poorer outcomes. Around 10 percent of patients with PDAC had very high levels of this protein in their tumor cells.
To understand why CD9 made the cancer stronger, the researchers looked at how cancer stem cells obtain the energy they need to grow. They found that CD9 helps tumor cells absorb more of a nutrient called glutamine. Glutamine is a type of amino acid that cells use as fuel. Many cancer cells rely heavily on glutamine because it helps them grow quickly and divide rapidly.
With the help of CD9, cancer stem cells are able to take in more glutamine and gain more energy. This extra fuel allows the cancer to expand more aggressively. Because of this discovery, scientists now believe that blocking CD9 or limiting the ability of tumor cells to absorb glutamine might slow down the disease.
If future drugs can interrupt this process, doctors might be able to weaken cancer stem cells by cutting off their fuel supply. In simple terms, the treatment would aim to starve the most dangerous cancer cells so they can no longer grow or spread.
Although this research is still in an early stage and more studies are needed, the findings represent an exciting step forward. Pancreatic cancer has long been one of the hardest cancers to treat. Discoveries like this provide valuable clues that could guide the development of new therapies in the future.
Scientists hope that by better understanding how cancer stem cells survive and grow, they can design smarter treatments that target the root of the disease. While it may take years before such treatments become available to patients, studies like this give new hope that pancreatic cancer may one day become easier to fight.
If you care about cancer, please read studies about common drugs for inflammation may help kill cancer, and statin drugs can starve cancer cells to death.
For more information about cancer, please see recent studies about these two things are key to surviving cancer and results showing common Indian fruit may slow down cancer growth.
Copyright © 2026 Knowridge Science Report. All rights reserved.
